Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1279: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A a multi-center, randomized, parallel-controlled, non-inferiority clinical trial

Presenter: Shasha Chen

October 27, 2025

Presentation TCT 2025

TCT 1742: Novel Hybrid Surgical Repair Technique for Post-Infarct Pseudoaneurysm Using a Cardioform Septal Occluder After Successful 3D Printing Predictive Modeling

Presenter: Michael Stephen Axline

October 27, 2025

Presentation TCT 2025

TCT 311: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A multi-center, randomized, parallel-controlled, non-inferiority clinical trial

Presenter: Shasha Chen

October 26, 2025

Presentation TCT 2023

TCT 920: Stuck Saucer: A Rare Coplication of Atrial Septal Occluder intervention

Presenter: Kachchakaduge Peiris

October 24, 2023

Presentation TCT 2022

TCT 734: Transcatheter Left Atrial Appendage Closure with a Gore Cardioform Septal Occluder in a Patient with Failed Surgical Left Atrial Exclusion

Presenter: Gordon Wong

September 18, 2022

Presentation TCT 2021

TCT 615: Decommissioning Of Left Ventricular Assist Device by Percutaneous Closure of Outflow Graft Using VSD occluder device and Amplatzer Vascular Plug

Presenter: Mohit Pahuja

November 04, 2021

Presentation TCT 2020

TCT 530: Successful Use of Cardioform Septal Occluder to Obliterate a Residual Lateral Commissural Jet Following Deployment of Mitraclip for Primary Mitral Regurgitation

Presenter: Jose Sleiman

October 14, 2020

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

Presenter: David R. Holmes Jr., Clifford J. Kavinsky, shantanu Deshpande

October 31, 2016

Presentation TCT 2016

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

Presenter: Horst Sievert

October 30, 2016

Presentation TCT 2015

TCT 31: Immediate and 1-Year US IDE Trial Results of the New GORE CARDIOFORM Septal Occluder for Transcatheter Closure of Secundum Atrial Septal Defects

Presenter: John P. Cheatham, Carlos Pedra, Joseph Paolillo

October 13, 2015

Advertisement

TCT 1279: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A a multi-center, randomized, parallel-controlled, non-inferiority clinical trial

TCT 1742: Novel Hybrid Surgical Repair Technique for Post-Infarct Pseudoaneurysm Using a Cardioform Septal Occluder After Successful 3D Printing Predictive Modeling

TCT 311: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A multi-center, randomized, parallel-controlled, non-inferiority clinical trial

TCT 920: Stuck Saucer: A Rare Coplication of Atrial Septal Occluder intervention

TCT 734: Transcatheter Left Atrial Appendage Closure with a Gore Cardioform Septal Occluder in a Patient with Failed Surgical Left Atrial Exclusion

TCT 615: Decommissioning Of Left Ventricular Assist Device by Percutaneous Closure of Outflow Graft Using VSD occluder device and Amplatzer Vascular Plug

TCT 530: Successful Use of Cardioform Septal Occluder to Obliterate a Residual Lateral Commissural Jet Following Deployment of Mitraclip for Primary Mitral Regurgitation

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

TCT 31: Immediate and 1-Year US IDE Trial Results of the New GORE CARDIOFORM Septal Occluder for Transcatheter Closure of Secundum Atrial Septal Defects

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content